SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22% SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22%

HLS Healius Limited

Healthcare · Diagnostics & Research · website · 3,343 employees
$0.40
52wk 0.30 – 1.07
Overall
10.9
Value
39.4
Growth
0.0
Health
0.0
Quality
4.6
Momentum
8.0
Dividend
—
Price
About Healius Limited

Healius Limited provides medical laboratory and pathology services in Australia. The company provides services under the Laverty Pathology, Dorevitch Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics Pathology, QML Pathology, TML Pathology, Abbott Pathology, IQ Pathology, Kossard, Gastrolab Dermatopathology, and Agilex Biolabs brands. It operates medical laboratories and patient collection centers. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.

Price analytics

Returns

1 day -6.0%
1 week 3.9%
1 month -14.1%
3 months 2.6%
6 months -24.8%
1 year -50.9%
3 years -80.6%

Risk

Volatility (1y ann.) 60.6%
Beta vs ASX 200 1.27
Sharpe (1y) -0.93
VaR 95% (1-day) -5.6%
Max drawdown (1y) -69.7%
Off 1-year high -62.0%

Technicals

RSI(14) 44
vs 50DMA -4.9%
vs 200DMA -27.9%
Trend Death cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown (2 Oct 2026)
Value 39.4
Trailing P/E
—
Forward P/E
0
PEG ratio
56
EV / EBITDA
0
Price / Book
88
Price / Sales
100
Growth 0.0
Revenue growth (1y)
0
Revenue CAGR (3y)
0
EPS growth (1y)
—
EPS CAGR (3y)
—
Financial Health 0.0
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
—
Current ratio
0
Debt / Equity
0
Quality (Profitability & Cash Flow) 4.6
Return on equity
0
Return on assets
12
Operating margin
9
Net margin
0
Cash conversion (OCF / net income)
—
Dividend / Income —
No meaningful dividend — pillar excluded from the overall score.
Momentum 8.0
6-month return vs ASX 200
0
Price vs 200-day average
0
Price vs 50-day average
26
Position in 52-week range
12

Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).

Score history
Key metrics
Market cap
$286.84M
P/E (trailing)
—
P/E (forward)
126.60
EPS (trailing)
-0.56
Dividend yield
—
Payout ratio
0.0%
Beta
0.29
EV / EBITDA
20.34
Price / Book
1.67
ROE
-107.7%
Operating margin
2.2%
Net margin
-30.3%
Total cash
$67.20M
Total debt
$996.40M
Current ratio
0.66
Debt / Equity
5.81
Free cash flow
$132.19M
Avg volume
4.80M
Latest annual results (FY ending 30 Jun 2026)
  • Revenue—
  • Gross profit—
  • Operating income—
  • Net income—
  • Diluted EPS-0.57
  • Free cash flow—
  • Net debt—
Sector peers (Healthcare)
TickerMkt cap P/EScore
CSL $84.15B — 54.3
RMD $45.86B 21.2 74.4
SIG $29.91B 43.3 55.6
FPH $21.64B 57.5 71.1
PME $16.34B 61.8 69.0
RHC $12.56B 40.0 40.2
SHL $9.12B 15.0 43.0
COH $8.20B 55.5 39.4